P3 Health Partners Inc (PIII)
0.3569
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 16:00
0.3569
0.00 (0.00%)
After-Hours: 18:56
P3 Health Partners Enterprise Value: 316.56M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 316.56M |
| November 01, 2024 | 318.38M |
| October 31, 2024 | 316.91M |
| October 30, 2024 | 319.50M |
| October 29, 2024 | 321.49M |
| October 28, 2024 | 322.25M |
| October 25, 2024 | 324.55M |
| October 24, 2024 | 329.93M |
| October 23, 2024 | 336.02M |
| October 22, 2024 | 330.03M |
| October 21, 2024 | 328.03M |
| October 18, 2024 | 332.30M |
| October 17, 2024 | 336.34M |
| October 16, 2024 | 318.69M |
| October 15, 2024 | 314.19M |
| October 14, 2024 | 309.99M |
| October 11, 2024 | 309.00M |
| October 10, 2024 | 309.36M |
| October 09, 2024 | 311.41M |
| October 08, 2024 | 317.40M |
| October 07, 2024 | 319.84M |
| October 04, 2024 | 320.00M |
| October 03, 2024 | 319.71M |
| October 02, 2024 | 321.78M |
| October 01, 2024 | 321.78M |
| Date | Value |
|---|---|
| September 30, 2024 | 321.34M |
| September 27, 2024 | 322.27M |
| September 26, 2024 | 320.65M |
| September 25, 2024 | 321.51M |
| September 24, 2024 | 321.96M |
| September 23, 2024 | 321.85M |
| September 20, 2024 | 328.41M |
| September 19, 2024 | 330.99M |
| September 18, 2024 | 333.27M |
| September 17, 2024 | 337.49M |
| September 16, 2024 | 339.54M |
| September 13, 2024 | 338.64M |
| September 12, 2024 | 339.74M |
| September 11, 2024 | 347.02M |
| September 10, 2024 | 340.03M |
| September 09, 2024 | 342.81M |
| September 06, 2024 | 333.27M |
| September 05, 2024 | 335.85M |
| September 04, 2024 | 334.04M |
| September 03, 2024 | 333.25M |
| August 30, 2024 | 340.50M |
| August 29, 2024 | 340.38M |
| August 28, 2024 | 334.85M |
| August 27, 2024 | 340.48M |
| August 26, 2024 | 340.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
309.00M
Minimum
Oct 11 2024
2.068B
Maximum
Mar 22 2022
926.14M
Average
699.80M
Median
Apr 17 2023
Enterprise Value Benchmarks
| American Shared Hospital Services | 31.12M |
| Novo Integrated Sciences Inc | 4.018M |
| Astrana Health Inc | 2.392B |
| Cryo-Cell International Inc | 68.02M |
| Biote Corp | 255.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.02M |
| Revenue (Quarterly) | 379.16M |
| Total Expenses (Quarterly) | 410.49M |
| EPS Diluted (Quarterly) | -0.15 |
| Profit Margin (Quarterly) | -3.17% |
| Earnings Yield | -187.7% |
| Normalized Earnings Yield | -202.81 |